The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets cautious ahead of risk events, Syria action

Wed, 04th Sep 2013 11:26

Traders adopted a cautious approach on Wednesday morning with UK stocks registering losses in morning trade ahead of a number of 'risk events' later in the week which have the potential to spark market volatility.Fears about impending US military action in Syria also hit investor sentiment today as support for a Western intervention continues to grow. Markets across Europe were trading in the red this morning, while stock futures in the US pointed to a weak start on Wall Street.The Senate Foreign Relations Committee last night gave the green light on a US attack on Syria, saying that the use of force "reflects the will and concerns of Democrats and Republicans alike". This comes ahead of the crucial vote in Congress next week on President Barack Obama's call for action against the Bashar al-Assad regime which he claims is responsible for the deadly chemical weapons attack against the Syrian people in August.It is set to be a busy end to the week with central-bank policy decisions expected on Thursday from the Bank of Japan, Bank of England and the European Central Bank. These will be followed by the all-important US jobs report on Friday which will be a large factor in the Federal Reserve's decision on whether or not to adjust current stimulus measures later this month.Services PMIs come in mixed"A combination of geopolitical concerns and hesitation before these big events forced us to look to economic data for fresh inspiration but readings from the Eurozone were less than impressive," said Market Strategist Ishaq Siddiqi from ETX Capital.After a series of better-than-expected manufacturing surveys from across the globe in recent days, data from the Eurozone services sector disappointed with activity growing by less than forecast in August. The Eurozone services purchasing managers' index (PMI) came in at 50.7, worse than the 51 estimate. Eurozone retail sales meanwhile increased by just 0.1% in July (forecast: +0.2%).In contrast, there was no letting up in the recent string of strong UK data this morning with the outlook for British economy continuing to brighten. The UK services PMI rose from 60.2 to 60.5 (forecast: 59.7), the highest level since December 2006."Following surprisingly strong gains in August's manufacturing and construction surveys, today's services result at face value points to quarterly [economic] growth in Q3 not far off a rip-roaring 2%," said Martin Beck, UK Economist from Capital Economics.FTSE 100: Airline stocks sink after Ryanair profit warningAirline peers easyJet and IAG were flying lower this morning after a gloomy outlook by Ryanair on the back of the hot weather in Northern Europe over the summer. The company scaled back its full-year profit guidance after worse-than-expected bookings but said that it could even fail to meet these forecasts if fares and yields continue to weaken over the coming winter.Hargreaves Lansdown fell despite reporting record annual figures this morning. Full-year pre-tax profit rose 28% to £195.2m as the financial services company took on more clients and increased assets under administration by 38% rise in AuA to £36.4bn. Weighing on the price this morning could be Morgan Stanley's downgrade of the 'Diversified Financial' sector to 'neutral'.TUI Travel, Resolution and BHP Billiton were also heavy fallers after going ex-dividend, meaning that from today new investors won't be able to get their hands on their latest dividend payments. Others that went ex-dividend on the blue-chip index include Admiral, Aggreko, ARM Holdings, IMI, Land Securities, Serco Group and Shire.Even chemicals group Croda International was lower after going ex-div, shrugging off an upgrade by Exane BNP Paribas to 'outperform'. Sector peer Johnson Matthey however was a high riser after JPMorgan Cazenove raised its target price from 2,600p to 2,800p. FTSE 250: Phoenix lower after going ex-divMicro Focus and Phoenix were among the worst performersthis morning after going ex-dividend. A host of others were also trading without the rights to their latest payouts, including 888 Holdings, Betfair, Elementis, esure, Greggs, Hikma Pharmaceuticals, Jardine Lloyd Thompson, Michael Page International, National Express Group, Polymetal International, Regus, SEGRO and Xaar.Kenmare Resources was higher after Goldman raised its recommendation to 'conviction buy', while Salamander Energy was boosted by a Morgan Stanley upgrade to 'equalweight'.FTSE 100 - RisersVodafone Group (VOD) 206.30p +1.88%Johnson Matthey (JMAT) 2,960.00p +1.47%Whitbread (WTB) 3,151.00p +1.06%Petrofac Ltd. (PFC) 1,410.00p +1.00%BG Group (BG.) 1,259.00p +0.96%Fresnillo (FRES) 1,288.00p +0.78%Experian (EXPN) 1,140.00p +0.53%Shire Plc (SHP) 2,398.00p +0.46%Intertek Group (ITRK) 3,246.00p +0.19%Rio Tinto (RIO) 3,064.00p +0.18%FTSE 100 - FallerseasyJet (EZJ) 1,200.00p -6.25%TUI Travel (TT.) 331.90p -3.99%Resolution Ltd. (RSL) 312.60p -3.93%International Consolidated Airlines Group SA (CDI) (IAG) 284.00p -3.63%Persimmon (PSN) 1,102.00p -3.50%Associated British Foods (ABF) 1,845.00p -2.95%Hargreaves Lansdown (HL.) 1,001.00p -2.91%Carnival (CCL) 2,316.00p -2.89%BHP Billiton (BLT) 1,890.00p -2.38%Standard Life (SL.) 331.90p -2.32%FTSE 250 - RisersBumi (BUMI) 223.00p +6.85%Kenmare Resources (KMR) 28.51p +4.82%Fisher (James) & Sons (FSJ) 1,136.00p +3.93%Enterprise Inns (ETI) 150.10p +3.88%Dechra Pharmaceuticals (DPH) 708.50p +2.98%COLT Group SA (COLT) 112.50p +2.93%St. Modwen Properties (SMP) 295.80p +2.74%Balfour Beatty (BBY) 262.70p +1.74%Smith (DS) (SMDS) 271.90p +1.64%Daejan Holdings (DJAN) 3,830.00p +1.46%FTSE 250 - FallersThomas Cook Group (TCG) 134.90p -5.40%Micro Focus International (MCRO) 731.50p -5.06%Ashtead Group (AHT) 654.00p -4.87%Phoenix Group Holdings (DI) (PHNX) 722.50p -4.30%Berkeley Group Holdings (The) (BKG) 2,083.00p -3.52%Barratt Developments (BDEV) 303.90p -3.52%Amlin (AML) 377.10p -3.28%Taylor Wimpey (TW.) 100.00p -3.01%Mitchells & Butlers (MAB) 433.90p -2.97%Diploma (DPLM) 618.00p -2.68%BC
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.